Cryptocurrency & Digital Assets

Following a period of mixed financials, Neogen appoints new leaders to drive innovation and growth in its critical global food safety division.

JetBlue is adding year-round flights to Dallas and Orlando from Fort Lauderdale, sparking new competition and promising more options for Florida travelers.

Activist investor YZi Labs accuses CEA Industries of entrenchment after it adopted a 'poison pill,' escalating a battle over board control and crypto strategy.

KIOXIA's new BG7 SSDs use breakthrough BiCS FLASH Gen 8 and CBA tech to deliver major speed and power efficiency gains for the next generation of PCs.

With a hot obesity pipeline and a key neurology asset, Nxera Pharma's J.P. Morgan talk is a crucial test of its plan for global leadership.

With stunning clinical data for its miv-cel therapy, Kyverna is set to outline a new era for autoimmune treatment at the J.P. Morgan conference.

At CES 2026, a new platform combines Dolby Atmos FlexConnect and UWB tech, promising to make high-end surround sound easier than ever before.

With a key presentation looming, Star Therapeutics aims to showcase its universal hemostatic therapy, VGA039, for von Willebrand disease.

With blockbuster sales from VYJUVEK, Krystal Biotech heads to J.P. Morgan with investors eager for news on its global growth and ambitious pipeline.

A new partnership between etherWhere and AsiaRF promises ultra-low power, high-precision location tracking for everything from police cameras to Wi-Fi 7.

EZCORP acquires a controlling stake in Founders One, adding 105 pawn stores and signaling a major consolidation in the alternative finance sector.

China's ETF market had a record 2025, fueled by AI breakthroughs and state support. A look at the boom, the leaders, and the risks ahead.

The new over-the-counter molecular test could deliver results in 30 minutes, aiming to revolutionize STI diagnostics and tap into a $1.5B market.

AMC Robotics establishes a new manufacturing hub in Ho Chi Minh City, a strategic move to scale its Kyro robot and join the global tech shift to Vietnam.

A landmark $1.2M order for its advanced LineaDNA validates the firm's biotech arm, but can scientific success balance its new, volatile crypto strategy?

Prenetics slashed future dilution risk by exchanging 4.7M warrants, a move analysts see as crucial for fueling the rapid growth of its IM8 wellness brand.

EchoStar's soaring stock price has triggered a conversion option for its 2030 notes, creating a pivotal choice between debt, cash, and equity.

As MRAM demand surges in critical sectors, Everspin Technologies prepares to detail its financial health and strategic roadmap at a key investor event.

A new drug could redefine life for polycythemia vera patients, replacing frequent, burdensome blood draws with a simple weekly self-injection.

In a major win, Rockwell Medical extends its DaVita supply deal through 2026 with a price hike, underscoring the value of its reliable supply chain.